1. External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice
   Xiaoxue Jiang et al, 2017, Immunopharmacology and Immunotoxicology CrossRef
2. Colonic stem cell from severe ulcerative colitis maintains environment-independent immune activation by altering chromatin accessibility and global m6A loss
   Chuandong Liu et al, 2023, Life Medicine CrossRef
3. Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-κB inhibition
   Xiaoxue Jiang et al, 2019, Immunopharmacology and Immunotoxicology CrossRef
4. Anti-inflammatory Effects of Ivermectin in the Treatment of Acetic Acid-Induced Colitis in Rats: Involvement of GABAB Receptors
   Armin Aryannejad et al, 2022, Digestive Diseases and Sciences CrossRef
5. Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review
   Yinzhi Lin et al, 2018, International Journal of Molecular Sciences CrossRef
6. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway
   Aliakbar Yousefi‐Ahmadipour et al, 2019, Journal of Cellular Physiology CrossRef
7. Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
   Jun Ma et al, 2021, Cells CrossRef
8. Protective Effects of SIRT6 Overexpression against DSS-Induced Colitis in Mice
   Kang Xu et al, 2020, Cells CrossRef
9. Polysaccharide fraction isolated from the leaves of Hordeum vulgare L. protects against colonic inflammation of systemic immune responses
   Hee-Soo Han et al, 2021, Journal of Functional Foods CrossRef